Clinical overview of venous thromboembolism

G. Schellack; T. Modau; N. Schellack

Clinical overview of venous thromboembolism

G. Schellack
, T. Modau
, N. Schellack^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

4 Citations (Scopus)

Abstract

Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE through a variety of factors, require adequate thromboprophylaxis. Primary and secondary prevention, as well as the definitive treatment of VTE, are accomplished through the use of a variety of anticoagulant drugs. This article attempts to provide an overview of VTE, and its prevention and treatment.

Original language	English
Pages (from-to)	9-16
Number of pages	8
Journal	SA Pharmaceutical Journal
Volume	88
Issue number	1
Publication status	Published - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Anticoagulants
Deep vein thrombosis
DVT
Embolus
NOAC
PE
Pulmonary embolism
Thromboprophylaxis
Thrombus
Venous thromboembolism
Virchow's triad
VTE

Cite this

@article{0cef9d9726f8455d9320659ae6b4fa16,

title = "Clinical overview of venous thromboembolism",

abstract = "Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE through a variety of factors, require adequate thromboprophylaxis. Primary and secondary prevention, as well as the definitive treatment of VTE, are accomplished through the use of a variety of anticoagulant drugs. This article attempts to provide an overview of VTE, and its prevention and treatment.",

keywords = "Anticoagulants, Deep vein thrombosis, DVT, Embolus, NOAC, PE, Pulmonary embolism, Thromboprophylaxis, Thrombus, Venous thromboembolism, Virchow's triad, VTE",

author = "G. Schellack and T. Modau and N. Schellack",

year = "2021",

month = jan,

day = "1",

language = "English",

volume = "88",

pages = "9--16",

journal = "SA Pharmaceutical Journal",

issn = "1015-1362",

publisher = "Medpharm Publications",

number = "1",

}

TY - JOUR

T1 - Clinical overview of venous thromboembolism

AU - Schellack, G.

AU - Modau, T.

AU - Schellack, N.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE through a variety of factors, require adequate thromboprophylaxis. Primary and secondary prevention, as well as the definitive treatment of VTE, are accomplished through the use of a variety of anticoagulant drugs. This article attempts to provide an overview of VTE, and its prevention and treatment.

AB - Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE through a variety of factors, require adequate thromboprophylaxis. Primary and secondary prevention, as well as the definitive treatment of VTE, are accomplished through the use of a variety of anticoagulant drugs. This article attempts to provide an overview of VTE, and its prevention and treatment.

KW - Anticoagulants

KW - Deep vein thrombosis

KW - DVT

KW - Embolus

KW - NOAC

KW - PE

KW - Pulmonary embolism

KW - Thromboprophylaxis

KW - Thrombus

KW - Venous thromboembolism

KW - Virchow's triad

KW - VTE

UR - https://www.scopus.com/pages/publications/84963761024

M3 - Review article

SN - 1015-1362

VL - 88

SP - 9

EP - 16

JO - SA Pharmaceutical Journal

JF - SA Pharmaceutical Journal

IS - 1

ER -

Clinical overview of venous thromboembolism

Abstract

UN SDGs

Keywords

Other files and links

Fingerprint

Cite this